Aequs: Sanction of Scheme of Amalgamation between Aequs Limited ("Transferee Company) and AeroStructures…
Aequs (AEQUS) filed a disclosure titled "Sanction of Scheme of Amalgamation between Aequs Limited ("Transferee Company) and AeroStructures Manufacturing India Private Limited, Aequs". The company is valued at about ₹14,727 crore.
What happened
Aequs (AEQUS) filed a disclosure with the exchanges on 6 November 2026 at 06:45 PM titled "Sanction of Scheme of Amalgamation between Aequs Limited ("Transferee Company) and AeroStructures Manufacturing India Private Limited, Aequs".
From the filing: "Aequs Limited has informed the Exchange about sanction of Scheme of Amalgamation between Aequs Limited ("Transferee Company) and AeroStructures Manufacturing India Private Limited, Aequs ...."
Company snapshot
Aequs is a small-cap company in the Capital Goods sector, with a market value of about ₹14,727 crore.
The stock last traded at ₹219.6, against a 52-week range of ₹113.3–₹294.7 (25.5% below the high).
Before this filing the shares had moved −22.8% over the month and −8.1% over three months. Average daily turnover over the last 20 sessions was about ₹134 crore.
Promoters held 59.09% at the end of Q2 FY27; 25.36% of promoter shares were pledged. Foreign institutions owned 5.93% and domestic institutions 9.27%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q3 FY26 | 326 | -42.7 | -0.7 |
| Q4 FY26 | 367 | -53.7 | -0.8 |
| Q1 FY27 | 396 | -53.2 | -0.81 |
| Q2 FY27 | 409 | -52.4 | -0.8 |
What history shows
BCEIE's records show 2 previous m&a filings from the company since May 2026.
After those filings, the stock gained 0.8% on average the next trading day and was up 0.3% on average after five days (2 filings with price data).
Across 185 similar disclosures by other Capital Goods companies, shares moved −0.2% on average the next day and −0.1% over five days; 46% of them rose the next day.
Market-wide, 2,349 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Oct 2026 | Aequs Limited has informed the Exchange about the receipt of order… | −2.2% | −7.3% |
| 19 Jun 2026 | M&A | +3.8% | +7.8% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Aequs Q2 results: Loss widens to ₹52 crore despite 45% revenue growth
- Aequs shares crash up to 19% post-Q2 loss; JM Financial maintains 'Reduce' rating
- Aequs AGM voting results show institutional dissent on new RSU plan
- Aerospace stock Aequs plunges 19% after Q2 results. Why are investors worried?
- Aequs shares tumble 19% as Q2 loss expands to ₹52 crore, EBITDA margin contracts; check numbers
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.